Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.4987
-0.0181 (-3.50%)
At close: Dec 12, 2025, 4:00 PM EST
0.5200
+0.0213 (4.27%)
After-hours: Dec 12, 2025, 7:54 PM EST
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $80.64 million as of December 12, 2025. Its market cap has decreased by -7.56% in one year.
Market Cap
80.64M
Enterprise Value
-6.92M
1-Year Change
-7.56%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $80.64M, a decrease of -73.27%. That is a compound annual growth rate of -22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 80.64M | -7.73% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |